<DOC>
	<DOC>NCT00473694</DOC>
	<brief_summary>The purpose of the trial is to demonstrate a faster recovery from neuromuscular block with rocuronium or vecuronium after reversal by 4.0 mg/kg of Org 25969 compared with reversal by 70 Î¼g/kg of neostigmine</brief_summary>
	<brief_title>Comparison of Sugammadex With Neostigmine Administered at 1-2 PTCs After Administration of Rocuronium or Vecuronium (19.4.302)(P05945)</brief_title>
	<detailed_description />
	<mesh_term>Neostigmine</mesh_term>
	<mesh_term>Vecuronium Bromide</mesh_term>
	<mesh_term>Rocuronium</mesh_term>
	<criteria>ASA Class 1 to 4; 18 years or older; Scheduled for elective surgical procedure under general anesthesia requiring neuromuscular block for intubation and maintenance; Scheduled for surgery in supine position; Given written informed consent; Subjects in whom a difficult intubation is expected due to anatomical malformations; Subjects known or suspected to have neuromuscular disorders impairing neuromuscular blockade and/or significant renal dysfunction; Subjects known or suspected to have a (family) history of malignant hyperthermia; Subjects known or suspected to have an allergy to narcotics, muscle relaxants or other medications used during surgery; Subjects receiving medication known to interfere with neuromuscular blocking agents such as anticonvulsants, antibiotics and Mg2+; Subjects in whom the use of neostigmine and/or glycopyrrolate may be contraindicated; Female subjects who are pregnant or breastfeeding; Females subjects of childbearing potential not using an acceptable method of birth control [condom or diaphragm with spermicide, vasectomized partner (&gt; 6 months), IUD, abstinence]; Subjects who had already participated in an Org 25969 trial including Protocol 19.4.302; Subjects who had participated in another clinical trial, not preapproved by Organon, within 30 days of entering into Protocol 19.4.302.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>